News | February 20, 2022
GSK pauses phase III RSV maternal vaccine candidate programme
This decision does not impact the ongoing AReSVi 006 phase III trial for RSV older adults.
This decision does not impact the ongoing AReSVi 006 phase III trial for RSV older adults.
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada
TRIS AMINO HCl is widely used as a diagnostic reagent and as a downstream processing buffer in the purification of commercial biopharmaceuticals
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Rapid testing produces air sample results in 30 minutes
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
Subscribe To Our Newsletter & Stay Updated
